Related Experiment Video

Updated: Aug 14, 2026

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
05:23

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

Intravenous iron dextran and erythropoietin use in pediatric hemodialysis patients

L A Greenbaum1, C G Pan, C Caley

  • 1Department of Pediatrics, Medical College of Wisconsin, Milwaukee 53226, USA. Lgreen@post.its.mcw.edu

Pediatric Nephrology (Berlin, Germany)
|September 7, 2000
PubMed

Insights

Intravenous iron dextran effectively reduces recombinant human erythropoietin (rHuEPO) requirements in pediatric hemodialysis patients with anemia. This treatment optimizes iron levels, leading to decreased rHuEPO doses and improved anemia management.

Area of Science:

  • Nephrology
  • Pediatric Hematology
  • Clinical Nutrition

Background:

  • Anemia is a common complication of chronic renal failure.
  • Recombinant human erythropoietin (rHuEPO) is a standard treatment for anemia in dialysis patients.
  • Adequate iron status is crucial for an effective rHuEPO response.

Purpose of the Study:

  • To evaluate the impact of an intravenous iron dextran protocol on rHuEPO requirements in pediatric hemodialysis patients.
  • To assess the utility of serum ferritin and transferrin saturation (TSAT) in identifying iron deficiency in this population.

Main Methods:

  • Prospective evaluation of pediatric hemodialysis patients receiving intravenous iron dextran.
  • Iron dextran administered over ten consecutive dialysis sessions (4 mg/kg/session, max 100 mg).
  • rHuEPO dosage adjusted to maintain hematocrit between 33% and 36%.

Main Results:

  • A significant decrease in mean rHuEPO dose was observed 2 months post-iron treatment (3,784 to 2,115 units, P<0.005).
  • Transferrin saturation (TSAT) < 20% demonstrated high specificity for detecting iron deficiency.
  • Serum ferritin levels were found to be less reliable indicators of iron deficiency in this cohort.

Conclusions:

  • Intravenous iron dextran is effective in reducing rHuEPO requirements in pediatric hemodialysis patients.
  • TSAT < 20% is a reliable marker for iron deficiency in this patient group.
  • Iron repletion is essential for optimizing anemia treatment in pediatric renal failure.

More Related Videos

Dynamic Light Scattering Analysis for the Determination of the Particle Size of Iron-Carbohydrate Complexes04:40

Dynamic Light Scattering Analysis for the Determination of the Particle Size of Iron-Carbohydrate Complexes

Published on: July 7, 2023

A Comprehensive Pipeline to Assess the Efficiency of Human Erythropoiesis In Vitro and Ex Vivo08:53

A Comprehensive Pipeline to Assess the Efficiency of Human Erythropoiesis In Vitro and Ex Vivo

Published on: January 10, 2025

Related Concept Videos

Peritoneal Dialysis I: Introduction and Procedure01:30

Peritoneal Dialysis I: Introduction and Procedure

Peritoneal dialysis (PD) is a procedure that facilitates the exchange of solutes, waste products, electrolytes, and excess fluid between the blood in the peritoneal capillaries and a dialysis solution introduced into the peritoneal cavity.Principles of Peritoneal Dialysis (PD)Diffusion: Waste products such as urea and electrolytes move from high concentrations in the blood to low concentrations in the dialysate across the peritoneal membrane. This mechanism is driven by the concentration...
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this measurement...
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...